Population-Based Assessment of Clinical Risk Factors for Legionnaires' Disease
- PMID: 31617567
- PMCID: PMC9067372
- DOI: 10.1093/cid/ciz771
Population-Based Assessment of Clinical Risk Factors for Legionnaires' Disease
Abstract
We used US population-based surveillance data to characterize clinical risk factors for Legionnaires' disease (LD). The LD incidence increased by age and the risk was elevated for 12 clinical conditions, when compared to healthy adults. This information can be used to guide testing, treatment, and public health prevention efforts.
Keywords: Legionnaires’ disease; diagnosis; outbreak prevention; outbreak response; risk factors.
Published by Oxford University Press for the Infectious Diseases Society of America 2019.
Conflict of interest statement
References
-
- Dooling KL, Toews KA, Hicks LA, et al. Active bacterial core surveillance for Legionellosis - United States, 2011–2013. MMWR Morb Mortal Wkly Rep 2015; 64:1190–3. - PubMed
-
- Heath CH, Grove DI, Looke DF. Delay in appropriate therapy of Legionella pneumonia associated with increased mortality. Eur J Clin Microbiol Infect Dis 1996; 15:286–90. - PubMed
-
- Storch G, Baine WB, Fraser DW, et al. Sporadic community-acquired Legionnaires’ disease in the United States. A case-control study. Ann Intern Med 1979; 90:596–600. - PubMed
-
- Straus WL, Plouffe JF, File TM Jr, et al. Risk factors for domestic acquisition of Legionnaires disease. Arch Intern Med 1996; 156:1685–92. - PubMed
-
- Den Boer JWNJ, Friesema I. Risk factors for sporadic community-acquired Legionnaires’ disease. A 3-year national case-control study. Public Health 2006; 120: 566–71. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials